Maternal Serum C-Reactive Protein Concentration Early in Pregnancy and Subsequent Pregnancy Loss

ABSTRACT

The purpose of this study was to determine the relationship between maternal inflammation and first or second trimester pregnancy loss. A nested case-control analysis was performed among the cohort enrolled in the Oral Conditions and Pregnancy study. We compared maternal serum C-reactive protein concentration between women with a pregnancy loss at < 21 weeks gestation to control women without gestational diabetes or preeclampsia who delivered at term. Participants were 2:1 frequency matched to cases by maternal age, race, and prior preterm birth. Median concentration of serum C-reactive protein between cases and controls was compared using Wilcoxon rank sum test. The potential effects of maternal smoking, gestational age at blood draw, and insurance status were evaluated and an adjusted odds ratio (95% confidence interval) for pregnancy loss was calculated using multivariable logistic regression. Among 1224 participants, 102 (9.8%) experienced pregnancy loss and 44 had complete information available. Median serum C-reactive protein concentration was significantly higher in controls compared with all cases (3.2 versus 0.5 μg/mL; p < 0.001). However, when stratified by gestational age at the time of the loss, median serum C-reactive protein level among controls was similar to those with a loss at less than 12 weeks (3.2 versus 2.0 μg/mL) but significantly higher compared with those whose loss occurred at greater than 12 weeks gestation (3.2 versus 0.5 μg/mL; p < 0.05). After adjusting for maternal smoking, gestational age at blood draw, and insurance status, women whose serum C-reactive protein level was greater than the 75% percentile had a decreased odds ratio for pregnancy loss (0.20; 95% confidence interval, 0.06 to 0.65). Pregnancy loss is not associated with increased systemic inflammation as measured by maternal serum C-reactive protein. Future study should be directed at determining the role of maternal inflammation during early pregnancy development and placentation.

C-reactive protein - miscarriage - inflammation

REFERENCES

• 1 Duff P. Maternal and perinatal infection. In: Gabbe S, Niebyl J, Simpson J Obstetrics: Normal and Problem Pregnancies Philadelphia; Churchill Livingstone 2002: 1293-1345
• 2 Ralph S G, Rutherford A J, Wilson J D. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study.  BMJ. 1999;  319 220-223
• 3 Ridker P M, Rifai N, Rose L, Buring J E, Cook N R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.  N Engl J Med. 2002;  347 1557-1565
• 4 Ridker P M, Hennekens C H, Buring J E, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.  N Engl J Med. 2000;  342 836-843
• 5 Fichtlscherer S, Rosenberger G, Walter D H, Breuer S, Dimmeler S, Zeiher A M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease.  Circulation. 2000;  102 1000-1006
• 6 Lieff S, Boggess K, Murtha A et al.. The oral conditions and pregnancy study: periodontal status of a cohort of pregnant women.  J Periodontol. 2004;  75 116-126
• 7 Fredricsson B, Gilljam H. Smoking and reproduction: short and long term effects and benefits of smoking cessation.  Acta Obstet Gynecol Scand. 1992;  71 580-592
• 8 Ness R B, Grisso J A, Hirschinger N et al.. Cocaine and tobacco use and the risk of spontaneous abortion.  N Engl J Med. 1999;  340 333-339
• 9 Mishra G D, Dobson A J, Schofield M J. Cigarette smoking, menstrual symptoms and miscarriage among young women.  Aust N Z J Public Health. 2000;  24 413-420
• 10 Simpson J. Fetal wastage. In: Gabbe S, Niebyl J, Simpson J Obstetrics: Normal and Problem Pregnancies Philadelphia; Churchill Livingstone 2002: 729-753
• 11 Pepys M B, Baltz M L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.  Adv Immunol. 1983;  34 141-212
• 12 Meier-Ewert H K, Ridker P M, Rifai N, Price N, Dinges D F, Mullington J M. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.  Clin Chem. 2001;  47 426-430
• 13 Rifai N, Tracy R P, Ridker P M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay.  Clin Chem. 1999;  45 2136-2141
• 14 Ross R. Atherosclerosis: an inflammatory disease.  N Engl J Med. 1999;  340 115-126
• 15 Silver R, Branch D. The immunology of pregnancy. In: Creasy R, Resnik R Maternal Fetal Medicine. Philadelphia; WB Saunders 1999: 72-79